American Drug Index
Seiten
2012
|
57th Revised edition
Facts & Comparisons,U.S. (Verlag)
978-1-57439-337-8 (ISBN)
Facts & Comparisons,U.S. (Verlag)
978-1-57439-337-8 (ISBN)
- Titel erscheint in neuer Auflage
- Artikel merken
Zu diesem Artikel existiert eine Nachauflage
Provides an explanation and correlation of thousands of pharmaceuticals to medical, pharmaceutical, and allied health professionals. This book includes composition, strength, doseform, packaging, schedule, and usage for approximately 22,000 brand and official USP generic drugs.
For over 50 years, American Drug Index has provided explanation and correlation of thousands of pharmaceuticals to medical, pharmaceutical, and allied health professionals. This exhaustive drug listing includes composition, strength, doseform, packaging, schedule, and usage for approximately 22,000 brand and official USP generic drugs. Organized in an easy-to-follow dictionary format with extensive cross-referencing, American Drug Index includes Tall Man lettering and hard-to-find generic drug pronunciations. Appendices provide valuable information on oral doseforms that should not be crushed or chewed, drug names that look and sound alike, weights and measures, approximate practical equivalents, normal laboratory values, and a manufacturer and distributor listing. What's New: New Drugs including: Dalfampridine (Amprya); Ecallantide (Kalbitor); Liraglutide (Victoza); Pralactrexate (Folotyn); Romidepsin (Istodax); Sipuleucel-T (Provenge); Tocilizumab (Actemra); and Ustekinumab (Stelara).
For over 50 years, American Drug Index has provided explanation and correlation of thousands of pharmaceuticals to medical, pharmaceutical, and allied health professionals. This exhaustive drug listing includes composition, strength, doseform, packaging, schedule, and usage for approximately 22,000 brand and official USP generic drugs. Organized in an easy-to-follow dictionary format with extensive cross-referencing, American Drug Index includes Tall Man lettering and hard-to-find generic drug pronunciations. Appendices provide valuable information on oral doseforms that should not be crushed or chewed, drug names that look and sound alike, weights and measures, approximate practical equivalents, normal laboratory values, and a manufacturer and distributor listing. What's New: New Drugs including: Dalfampridine (Amprya); Ecallantide (Kalbitor); Liraglutide (Victoza); Pralactrexate (Folotyn); Romidepsin (Istodax); Sipuleucel-T (Provenge); Tocilizumab (Actemra); and Ustekinumab (Stelara).
Erscheint lt. Verlag | 1.11.2012 |
---|---|
Verlagsort | Philadelphia |
Sprache | englisch |
Maße | 152 x 229 mm |
Gewicht | 1044 g |
Themenwelt | Schulbuch / Wörterbuch ► Lexikon / Chroniken |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Medizin / Pharmazie ► Pflege | |
Medizin / Pharmazie ► Pharmazie ► PTA / PKA | |
ISBN-10 | 1-57439-337-5 / 1574393375 |
ISBN-13 | 978-1-57439-337-8 / 9781574393378 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Arzneimittelverzeichnis für Deutschland (einschließlich …
Buch | Hardcover (2024)
Rote Liste Service GmbH (Verlag)
CHF 149,95
Englisch für Apotheker und PTAs
Buch | Spiralbindung (2024)
Kohlhammer (Verlag)
CHF 44,75